Michel van der Veen
Founder, Peptalis
Founder of Peptalis. Writes the platform's knowledge layer: compound profiles, evidence reviews and the quality methodology. Works from primary literature — PubChem for chemistry, PubMed for studies — and states explicitly where evidence is absent.
Profile on LinkedIn
Who writes
Michel van der Veen, founder of Peptalis. Writes the platform's knowledge layer: compound profiles, evidence reviews and the quality methodology. Works from primary literature — PubChem for chemistry, PubMed for studies — and states explicitly where evidence is absent.
Peptalis was set up to describe what research shows and where it stops. That limit is named inside each article, not appended as a caveat.
How an article is produced
Chemistry is checked against PubChem; studies are checked against PubMed. Every PMID and DOI is verified against the primary source before publication.
Findings that could not be verified do not go live. Study size and research phase are always stated, so the reader sees how much material a statement rests on.
What the Peptalis Research Team is
Peptalis Research Team is the collective name for the editorial and verification work of the platform, not a separate group of staff.
No invented individuals are presented, and there is no external editorial board. Quality release of batches stays in the name of the organisation: certificates of analysis and batch documents are signed by Peptalis Quality, never by an individual author.
What is not here
No medical or therapeutic claims are made, and no dosing or usage guidance is given. The compounds in the catalogue are intended for laboratory research only.
Errors can be reported to research@peptalis.eu. Substantiated corrections are applied and dated in the article concerned.